Important pharmacy news and late-breaking industry information updated daily.

As pharmacists prepare for a surge in demand during this year’s flu season and the anticipated release of a COVID-19 vaccine, many state boards of pharmacy are engaged in discussions around allowing pharmacy technicians to participate in immunization administration, according to Ryan Burke, PharmD, director of professional affairs at the Pharmacy Technician Certification Board (PTCB).

Lawyers with the Justice Department have petitioned a bankruptcy judge not to force Purdue Pharma to relinquish certain documents as part of its Chapter 11 bankruptcy, even though those same disclosures informed the government's criminal investigation against the drugmaker.

Pharmacists got support from high places in a new resource aimed at creating comprehensive strategies to treat, control, and prevent hypertension (HTN). The Surgeon General’s Call to Action to Control Hypertension, or simply Call to Action (CTA), emphasizes pharmacists’ value to HTN efforts, as well as obstacles to their participation. The report is an initiative of U.S. Surgeon General Jerome Adams, MD, MPH, and was released in October 2020. Access the report at http://apha.us/CTA_HTN.

A growing number of colleges, as they try to keep coronavirus outbreaks at bay, are making influenza vaccination a requisite for enrollment. According to CDC, influenza immunization is particularly important this year, as health care systems struggle under the weight of COVID-19.

A recent study published in the Annals of Internal Medicine on September 22 showed that low-dose glucocorticoids may be linked to an increased risk for hospitalized infection in patients with rheumatoid arthritis (RA) receiving stable disease-modifying antirheumatic drug (DMARD) therapy. 

HHS and the U.S. Department of Defense announced Friday they have inked deals with CVS Health and Walgreens to provide and administer COVID-19 vaccines to residents and staff at long-term care facilities (LTCF) nationwide.

A recent study published in the Annals of Internal Medicine on September 22 showed that low-dose glucocorticoids may be linked to an increased risk for hospitalized infection in patients with rheumatoid arthritis (RA) receiving stable disease-modifying antirheumatic drug (DMARD) therapy.

A special committee of the National Academies of Science, Engineering, and Medicine (NASEM) tasked with developing a framework on the allocation and distribution of the COVID-19 vaccine agreed that pharmacists should be in the first group to be vaccinated.

FDA on Wednesday approved a combination of three monoclonal antibodies—atoltivimab, maftivimab, and odesivimab-ebgn (Inmazeb—Regeneron Pharmaceuticals)—as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adults and children. FDA Commissioner Stephen M.

A "potential safety concern" has interrupted clinical testing of an antibody-based COVID-19 treatment developed by Eli Lilly, which is administering it plus remdesivir to trial volunteers.